Related Experiment Video

Updated: Jun 12, 2026

Visualization of Pseudomonas aeruginosa within the Sputum of Cystic Fibrosis Patients
07:25

Visualization of Pseudomonas aeruginosa within the Sputum of Cystic Fibrosis Patients

Published on: July 16, 2020

Phlebovirus meningoencephalis complicated by Pseudomonas aeruginosa pneumonia: a case report

Vassiliki Anagnostou1, Maria Sdouga, Hellen Volakli

  • 1A' Department of Microbiology, Medical School, Aristotle University of Thessaloniki, Thessaloniki, Greece.

Vector Borne and Zoonotic Diseases (Larchmont, N.Y.)
|June 26, 2010
PubMed

Insights

A child in Greece experienced severe symptoms, including fever and convulsions, suggestive of a novel phlebovirus infection. The prolonged illness was complicated by hospital-acquired pneumonia, leading to residual ataxia.

Area of Science:

  • * Virology: Focuses on the identification and characterization of phleboviruses.
  • * Infectious Diseases: Investigates the clinical presentation and management of viral infections.
  • * Pediatrics: Addresses the specific health concerns and outcomes in children.

Background:

  • * Phleboviruses are known human pathogens transmitted by arthropods, causing various febrile illnesses.
  • * Toscana virus is a notable phlebovirus circulating in the Mediterranean region.
  • * Understanding phlebovirus epidemiology is crucial for public health surveillance.

Observation:

  • * An 8-year-old boy presented with high fever, tachypnea, hypotonia, diarrhea, and tonoclonic convulsions.
  • * Clinical diagnosis suggested a phlebovirus infection based on IgG seroconversion.
  • * Absence of IgM antibodies indicated a potential novel phlebovirus distinct from Toscana virus.

Findings:

  • * The patient exhibited symptoms consistent with acute phlebovirus infection.
  • * A hospital-acquired Pseudomonas aeruginosa pneumonia complicated the initial illness.
  • * The child required two months of hospitalization and presented with residual ataxia upon discharge.

Implications:

  • * This case highlights the potential for novel phleboviruses to cause severe illness in children.
  • * Prompt diagnosis and management are essential to prevent complications like hospital-acquired infections.
  • * Further research is needed to identify and characterize new phlebovirus strains and their associated clinical spectrum.

More Related Videos

Long Term Chronic Pseudomonas aeruginosa Airway Infection in Mice15:43

Long Term Chronic Pseudomonas aeruginosa Airway Infection in Mice

Published on: March 17, 2014

Murine Oropharyngeal Aspiration Model of Ventilator-associated and Hospital-acquired Bacterial Pneumonia04:32

Murine Oropharyngeal Aspiration Model of Ventilator-associated and Hospital-acquired Bacterial Pneumonia

Published on: June 28, 2018

Related Concept Videos

Pneumonia I: Introduction01:29

Pneumonia I: Introduction

Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...
Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Atypical Pneumonia01:14

Atypical Pneumonia

Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease include...
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
Pneumonia IV: Management01:28

Pneumonia IV: Management

The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Bacterial Meningitis I: Introduction01:22

Bacterial Meningitis I: Introduction

Bacterial meningitis is a severe, life-threatening inflammation of the meninges, particularly the pia mater and arachnoid mater, affecting the subarachnoid space, ventricles, and cerebrospinal fluid (CSF). If untreated, it can lead to significant neurological complications or death.Causative AgentsCommon pathogens vary with age and immune status. In adults, major organisms include Streptococcus pneumoniae, Neisseria meningitidis, and Haemophilus influenzae. Streptococcus agalactiae (group B...